Meinberger, D.; Hermes, G.; Brachvogel, B.; Sengle, G.; Elezagic, D.; Roth, A.; Ruthard, J.; Streichert, T.; Klatt, A.R.
CLEC3A-Derived Antimicrobial Peptides Reduce Staphylococcus aureus Bacterial Counts in an In Vivo Biomaterial-Associated Infection Mouse Model. Pharmaceutics 2025, 17, 234.
https://doi.org/10.3390/pharmaceutics17020234
AMA Style
Meinberger D, Hermes G, Brachvogel B, Sengle G, Elezagic D, Roth A, Ruthard J, Streichert T, Klatt AR.
CLEC3A-Derived Antimicrobial Peptides Reduce Staphylococcus aureus Bacterial Counts in an In Vivo Biomaterial-Associated Infection Mouse Model. Pharmaceutics. 2025; 17(2):234.
https://doi.org/10.3390/pharmaceutics17020234
Chicago/Turabian Style
Meinberger, Denise, Gabriele Hermes, Bent Brachvogel, Gerhard Sengle, Dzemal Elezagic, Annika Roth, Johannes Ruthard, Thomas Streichert, and Andreas R. Klatt.
2025. "CLEC3A-Derived Antimicrobial Peptides Reduce Staphylococcus aureus Bacterial Counts in an In Vivo Biomaterial-Associated Infection Mouse Model" Pharmaceutics 17, no. 2: 234.
https://doi.org/10.3390/pharmaceutics17020234
APA Style
Meinberger, D., Hermes, G., Brachvogel, B., Sengle, G., Elezagic, D., Roth, A., Ruthard, J., Streichert, T., & Klatt, A. R.
(2025). CLEC3A-Derived Antimicrobial Peptides Reduce Staphylococcus aureus Bacterial Counts in an In Vivo Biomaterial-Associated Infection Mouse Model. Pharmaceutics, 17(2), 234.
https://doi.org/10.3390/pharmaceutics17020234
